We have previously shown that histone deacetylase (HDAC) inhibition and cranial radiotherapy (RT) independently improve molecular and behavioral Alzheimer’s disease (AD)-like phenotypes. This evidence concerns the gene HDAC9 and early-onset autosomal dominant Alzheimer disease.